Concepedia

S Seyfried

SS

Statistics

Publications

7

Citations

1.1K

H-Index

7

Active since

2003

Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg(Current)

Novartis (Germany)

Johannes Gutenberg University Mainz

Harvard University

University Medical Center Freiburg

S Seyfried is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in life sciences, immunology, and immunotherapy.

Publications per year

2003–2011

7

Publications

7

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase

Marcus Maurer, Sabine Altrichter, Thomas Bieber et al. · Journal of Allergy and Clinical Immunology · 2011 · 357 citations · Full text

, , +10

Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co‐morbid seasonal allergic asthma

Matthias Kopp, Eckard Hamelmann, Stefan Zielen et al. · Clinical & Experimental Allergy · 2008 · 178 citations

, , +17

Heme Oxygenase–1 and Its Reaction Product, Carbon Monoxide, Prevent Inflammation–Related Apoptotic Liver Damage in Mice

Gabriele Sass, Miguel Che Parreira Soares, Kenichiro Yamashita et al. · Hepatology · 2003 · 160 citations · Full text

, , +15

Antiviral Activity and Hepatoprotection by Heme Oxygenase-1 in Hepatitis B Virus Infection

Ulrike Protzer, S Seyfried, Maria Quasdorff et al. · Gastroenterology · 2007 · 144 citations

, , +14

Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany

Stephanie Korn, Antje Thielen, S Seyfried et al. · Respiratory Medicine · 2009 · 119 citations · Full text

, , +12

1–5 of 7